Detalhe da pesquisa
1.
Improved overall survival for Stage III NSCLC patients treated with curative-intended therapy from 2010 to 2018-a cohort study in Denmark.
Acta Oncol
; 62(12): 1672-1679, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37699061
2.
SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells.
Blood
; 130(7): 881-890, 2017 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28634182
3.
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.
Blood
; 126(2): 233-41, 2015 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25957392
4.
Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts.
Br J Haematol
; 171(4): 478-90, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26255870
5.
EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB-IIIA non-small cell lung cancer in Norway-a nationwide cohort study.
Cancer Treat Res Commun
; 38: 100785, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190787
6.
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
Blood
; 118(24): 6239-46, 2011 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21998214
7.
Infections in patients with multiple sclerosis: A national cohort study in Sweden.
Mult Scler Relat Disord
; 45: 102420, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32736217
8.
A three-dimensional in vitro model of erythropoiesis recapitulates erythroid failure in myelodysplastic syndromes.
Leukemia
; 34(1): 271-282, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31375745
9.
The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts.
Leukemia
; 27(4): 889-896, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23070040